MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-05-0006920
Dr Jaks Pharma Private Limited
Dr Jaks Pharma Private Limited - chemicals in Cherlapally, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.28 Lakh
▼ 19% YoY
Net loss · FY 2025
₹50,451
Net margin -1.8%
EBITDA · FY 2025
₹2.25 Lakh
EBITDA margin 8.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Dr Jaks Pharma Private Limited
Data last updated:
Dr Jaks Pharma Private Limited is a private limited company based in Cherlapally, Telangana, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 30 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2016PTC112257. Its GSTIN is 36AAFCD8657G1ZC (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Jogula and Masaiah Jogula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No:343/P Syno :229 B N Reddy Nagar, Cherlapally, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.28 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹50,451 (net margin -1.8%) and EBITDA of ₹2.25 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 11% over five years.
Dr Jaks Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-05-0006920). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Dr Jaks Pharma Private Limited
CIN U24110TG2016PTC112257
Registration Number 112257
Incorporation Date 30 September 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-05-0006920
Recognitions & Rankings of Dr Jaks Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No:343/P Syno :229 B N Reddy Nagar, Cherlapally, Telangana, India – 500051
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
Comprehensive company report
Dr Jaks Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Dr Jaks Pharma Private Limited
The main business activity of Dr Jaks Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dr Jaks Pharma Private Limited FY 2025 filings available
Dr Jaks Pharma Private Limited reported revenue of ₹27.28 Lakh (down 19% YoY) for FY 2025.
Revenue · FY 2025
₹27.28 Lakh ▼ 19%
Net loss · FY 2025
₹50,451 margin -1.8%
EBITDA · FY 2025
₹2.25 Lakh margin 8.2%
Compounded Annual Growth Rate (CAGR) of Dr Jaks Pharma Private Limited
Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 14%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 16%
5 years · compounded
▲ 67%
Revenue fell 19% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dr Jaks Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.25 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹50,451 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dr Jaks Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dr Jaks Pharma are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dr Jaks Pharma Private Limited
Dr Jaks Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Jogula | Director | 30 Sep 2016 | 10 Years 0 Months | Current |
| Masaiah Jogula Also directs: Sree Bakthavastala Chits Private Limited | Director | 30 Sep 2016 | 10 Years 0 Months | Current |
Peer Comparison of Dr Jaks Pharma Private Limited
Dr Jaks Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Empaque International Private Limited | ₹27.35 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | Kanpur, Uttar Pradesh, India |
| Acciona Auto Engineering Private Limited | ₹27.35 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Indore, Madhya Pradesh, India |
| Maxima Herbal Care Private Limited | ₹27.33 Lakh (FY 2021) | •••• | •••• | -17.0% | •••• | Haridwar, Uttarakhand, India |
| Habilecare Pharma Private Limited | ₹27.3 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Jaipur, Rajasthan, India |
| Vogue Lifestyle Private Limited | ₹27.29 Lakh (FY 2023) | •••• | •••• | •••• | Sola, Gujarat, India | |
| Dr Jaks Pharma Private Limited this company | ₹27.28 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Cherlapally, Telangana, India |
| Aavo Chem Industries Private Limited | ₹27.26 Lakh (FY 2024) | •••• | •••• | -44.0% | •••• | Gwalior, Madhya Pradesh, India |
| Amarnarain Industries Private Limited | ₹27.24 Lakh (FY 2024) | •••• | •••• | 695.0% | •••• | Bareilly, Uttar Pradesh, India |
| Kryogenic Air Products Private Limited | ₹27.22 Lakh (FY 2025) | •••• | •••• | -56.0% | •••• | Uttar Pradesh, India |
| Green Hat Chemicals Private Limited | ₹27.19 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Ankleshwar, Gujarat, India |
| Palghar Aromas Private Limited | ₹27.16 Lakh (FY 2021) | •••• | •••• | 2616.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Dr Jaks Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Dr Jaks Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dr Jaks Pharma Private Limited
Dr Jaks Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dr Jaks Pharma Private Limited
Employment history and EPFO contributions of people linked to Dr Jaks Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dr Jaks Pharma Private Limited
Dr Jaks Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Anil Kumar Jogula was appointed as Director on 30 Sep 2016.
AGM
Dr Jaks Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dr Jaks Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Anil Kumar Jogula was appointed as Director.
Appointed
Masaiah Jogula was appointed as Director.
Incorporation
30 Sep 2016
Dr Jaks Pharma Private Limited was registered on 30 Sep 2016 with Roc Hyderabad & aged 10 years 21 days as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Dr Jaks Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dr Jaks Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dr Jaks Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dr Jaks Pharma Private Limited
Dr Jaks Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCD8657G1ZC | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dr Jaks Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dr Jaks Pharma Private Limited
Dr Jaks Pharma is an active private limited company based in Cherlapally, Telangana, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 30 September 2016 (10+ years old) and is registered under CIN U24110TG2016PTC112257.
Dr Jaks Pharma reported revenue of ₹27.28 Lakh for FY 2025 (down 19% YoY).
Dr Jaks Pharma has 2 current directors:
- Anil Kumar Jogula - Director
- Masaiah Jogula - Director
Dr Jaks Pharma reported a net loss of ₹50,451 (net margin -1.8%) and EBITDA of ₹2.25 Lakh (EBITDA margin 8.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dr Jaks Pharma is -14% over three years and 11% over five years. In the latest year (FY 2025) revenue fell 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dr Jaks Pharma is 36AAFCD8657G1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Dr Jaks Pharma is U24110TG2016PTC112257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr Jaks Pharma was incorporated on 30 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Dr Jaks Pharma by revenue are Empaque International Private Limited, Acciona Auto Engineering Private Limited, Maxima Herbal Care Private Limited, Habilecare Pharma Private Limited, Vogue Lifestyle Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Kumar Jogula was appointed as Director on 30 Sep 2016. Masaiah Jogula was appointed as Director on 30 Sep 2016.
Yes, Dr Jaks Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-05-0006920).